2020 Vitiligo International Symposium – Iltefat H. Hamzavi, MD, FAAD
Title
Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical Characteristics
Global Vitiligo Foundation
400 Winding Creek Blvd.
Mechanicsburg, PA 17050
USA
Phone: 866-777-1277
Email: info@globalvitiligofoundation.org
Website: globalvitiligofoundation.org
GVF Email List
We hate spam as much as the next person. We do what we can to pinpoint emails to the right person with the right subject matter. We will not sell your information to another company or organization.
To be added to the GVF email list complete this quick form.
Follow us on Facebook
Disclaimer
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment.
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.
